PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina 27710, USA; email: barton.haynes@duke.edu.\', \'Department of Medicine, Duke University School of Medicine, Durham, North Carolina 27710, USA.\', \'Department of Pathology, Duke University School of Medicine, Durham, North Carolina 27710, USA.\', \'Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA.\', \'Department of Immunology, Duke University School of Medicine, Durham, North Carolina 27710, USA.\', \'Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina 27710, USA.\', \'Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina 27710, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1146/annurev-med-042420-113838
?:hasPublicationType
?:journal
  • Annual review of medicine
is ?:pmid of
?:pmid
?:pmid
  • 34428080
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.79
?:rankingScore_hIndex
  • 142
?:title
  • SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34428080>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34428080>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all